Distinct effects of V617F and exon12-mutated JAK2 expressions on erythropoiesis in a human induced pluripotent stem cell (iPSC)-based model
Abstract Activating mutations affecting the JAK-STAT signal transduction is the genetic driver of myeloproliferative neoplasms (MPNs) which comprise polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis. The JAK2p.V617F mutation can produce both erythrocytosis in PV and thrombocyt...
Main Authors: | Nungruthai Nilsri, Panchalee Jangprasert, Jaturawat Pawinwongchai, Nipan Israsena, Ponlapat Rojnuckarin |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-83895-6 |
Similar Items
-
Mutated JAK2 signal transduction in human induced pluripotent stem cell (iPSC)-derived megakaryocytes
by: Jaturawat Pawinwongchai, et al.
Published: (2022-07-01) -
Regulation of platelet numbers and sizes by signaling pathways
by: Jaturawat Pawinwongchai, et al.
Published: (2021-11-01) -
Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera
by: Dan Liu, et al.
Published: (2021-09-01) -
Suspension culture improves iPSC expansion and pluripotency phenotype
by: Nerea Cuesta-Gomez, et al.
Published: (2023-06-01) -
PB2178: EVALUATION OF JAK2 EXON 12 MUTATIONS IN PATIENTS WITH JAK2 (V617F)-NEGATIVE POLYCYTHEMIA VERA
by: Sahar Khosravi, et al.
Published: (2023-08-01)